BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C, Corso G. Frequency of CDH1 Germline Mutations in Non-Gastric Cancers. Cancers (Basel) 2021;13:2321. [PMID: 34066044 DOI: 10.3390/cancers13102321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Cozzi G, Musi G, Ferro M, Cioffi A, de Cobelli O, Corso G. Progress in prostate cancer prevention. Eur J Cancer Prev 2022:CEJ. [PMID: 35352690 DOI: 10.1097/CEJ.0000000000000745] [Reference Citation Analysis]
2 Corso G. Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management. Journal of Surgical Oncology. [DOI: 10.1002/jso.26847] [Reference Citation Analysis]
3 Adib E, El Zarif T, Nassar AH, Akl EW, Abou Alaiwi S, Mouhieddine TH, Esplin ED, Hatchell K, Nielsen SM, Rana HQ, Choueiri TK, Kwiatkowski DJ, Sonpavde G. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 2021. [PMID: 34949788 DOI: 10.1038/s41416-021-01673-7] [Reference Citation Analysis]
4 Hua H, Zhang H, Chen J, Wang J, Liu J, Jiang Y. Targeting Akt in cancer for precision therapy. J Hematol Oncol 2021;14:128. [PMID: 34419139 DOI: 10.1186/s13045-021-01137-8] [Reference Citation Analysis]